M Alan Brookhart

Publications

GSK M Alan Brookhart Emory University Amgen Inc.University of North Carolina at Chapel Hill Abstract/Manuscript Aarhus University Jennifer B. Christian Approval & Commercialization Yes Regeneron Pharmaceuticals National Cheng Kung University R&D Columbia University

Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real-World Evidence.

Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real-World Evidence

M Alan Brookhart Nuvan Rathnayaka University of North Carolina at Chapel Hill Abstract/Manuscript Kayla Hendrickson Care Yes Kathleen E Hurwitz R&D

Propensity Score Methods for Confounding Control in Observational Studies of Therapeutics for COVID-19 Infection.

Propensity Score Methods for Confounding Control in Observational Studies of Therapeutics for COVID-19 Infection

Kathleen Hurwitz M Alan Brookhart Catherine Wiener Approval & Commercialization Yes Chase D. Latour Oral Presentation R&D

Comparing causal estimands from a sequential nested trial emulation with a treatment decision design to a conventional single point randomized trial: A simulation study.

Comparing causal estimands from a sequential nested trial emulation with a treatment decision design to a conventional single point randomized trial: A simulation study

M Alan Brookhart University of North Carolina at Chapel Hill Abstract/Manuscript David Pritchard Approval & Commercialization Yes Amgen R&D

Pragmatic considerations for negative control outcome studies to guide non-randomized comparative analyses: A narrative review.

Pragmatic considerations for negative control outcome studies to guide non-randomized comparative analyses: A narrative review

M Alan Brookhart Catherine Wiener University of North Carolina at Chapel Hill Abstract/Manuscript Care Yes University of Alabama at Birmingham R&D

Lipid Testing Trends Before and After Hospitalization for Myocardial Infarction Among Adults in the United States, 2008-2019.

Lipid Testing Trends Before and After Hospitalization for Myocardial Infarction Among Adults in the United States, 2008-2019

Publications

Total Publications

2025 · GSK

Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real-World Evidence.

2024 · M Alan Brookhart

Propensity Score Methods for Confounding Control in Observational Studies of Therapeutics for COVID-19 Infection.

2024 · Kathleen Hurwitz

Comparing causal estimands from a sequential nested trial emulation with a treatment decision design to a conventional single point randomized trial: A simulation study.

2023 · M Alan Brookhart

Pragmatic considerations for negative control outcome studies to guide non-randomized comparative analyses: A narrative review.

2022 · M Alan Brookhart

Lipid Testing Trends Before and After Hospitalization for Myocardial Infarction Among Adults in the United States, 2008-2019.

2022 · M Alan Brookhart

In-Hospital Treatment Patterns Among Patients Hospitalized with COVID-19 in the United States.

2022 · M Alan Brookhart

Discharged Where? The Importance of Understanding Discharge Dispositions When Estimating In-Hospital Mortality.

2022 · M Alan Brookhart

Fracture Risk Estimation in Post-menopausal Women: A Comparison of Machine Learning Methods and Software Systems.

2022 · M Alan Brookhart

Risk Factors for Mortality and Intensive Care Requirements Among Pediatric Patients Hospitalized with COVID-19 in the United States.

2022 · M Alan Brookhart

The Effect of Remdesivir for The Treatment of COVID-19 on Mortality Among Hospitalized Patients.

2022 · M Alan Brookhart

Negative Control Outcomes to Assess the Comparability of Biologics versus Small-molecule Therapeutics for Osteoporosis: Considerations for Differential Non-adherence.

2021 · M Alan Brookhart

Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies.

2020 · M Alan Brookhart

Who are we missing? Underrepresentation of data sources used for pharmacoepidemiology research in the United States.

2019 · M Alan Brookhart

Using Instrumental Variables to Address Bias from Unobserved Confounders.

2019 · M Alan Brookhart

Informative censoring by health plan disenrollment among commercially insured adults.

2019 · M Alan Brookhart

Nonparametric Bounds for the Risk Function.

Macro photograph of translucent oil bubbles on a vibrant orange and red gradient background, evoking scientific and biological imagery.

Contact us

By submitting this form, you consent to your information used by Headwater Science for the purpose of contacting you to better understand your potential interest in Headwater Science and/or its services. For more information, see our privacy policy.